Phase Ib-II trial reports improved survival outcomes in patients receiving combined therapy, suggesting benefits for future treatments.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: